Trial ID or NCT#

NCT01728116

Status

NOT RECRUITING

Purpose

To determine if the EndoBarrier safely and effectively improves glycemic control in obese subjects with type 2 diabetes

Official Title

A Randomized, Multi-Center, Pivotal Efficacy and Safety Study Comparing the EndoBarrier Gastrointestinal Liner System vs. Sham for Glycemic Improvement in Inadequately Controlled Obese Type 2 Diabetic Subjects on Oral Anti-Diabetes Agents

Eligibility Criteria

Ages Eligible for Study: 21 Years to 65 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No

Investigator(s)

Tracey McLaughlin
Endocrinologist
Professor of Medicine (Endocrinology) at the Stanford University Medical Center
Marilyn Tan
Endocrinologist
Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism

Contact us to find out if this trial is right for you.

CONTACT

Elizabeth Colbert
(650) 723-3186